Glutathione-S-transferase activates novel alkylating agents

Area of Science:

• Medicinal Chemistry
• Biochemistry
• Cancer Biology

Background:

• Glutathione-S-transferases (GSTs) are enzymes involved in detoxification.
• Targeted drug delivery systems can enhance chemotherapeutic efficacy.
• Alkylating agents are a class of cytotoxic drugs used in cancer treatment.

Purpose of the Study:

• To design and synthesize novel alkylating agents activated by GSTs.
• To evaluate the in vitro and in cellulo activity of these compounds.
• To investigate the role of specific GST isozymes in drug activation and sensitivity.

Main Methods:

• Multistep chemical synthesis of novel compounds.
• Enzymatic cleavage assays using recombinant human GSTs (A1-1, M1a-1a, P1-1).
• High-performance liquid chromatography (HPLC) and mass spectrometry for analysis.
• Cell culture studies using MCF-7 breast cancer cells, including transfected cell lines overexpressing P1-1 GST.

Main Results:

• Compounds 2 and 3 were synthesized and shown to be differentially cleaved by GSTs.
• M1a-1a GST liberated the cytotoxic phosphate moiety from compound 2.
• Compounds 2 and 3 exhibited cytotoxicity against MCF-7 cells (IC50s ~40 µM).
• MCF-7 cells overexpressing P1-1 GST showed increased sensitivity to compounds 2 and 3 (IC50s ~10-20 µM).

Conclusions:

• Novel GST-activated alkylating agents (compounds 2 and 3) demonstrate promising cytotoxic activity.
• Drug efficacy is modulated by specific GST isozymes, particularly P1-1 GST.
• Higher intracellular levels of P1-1 GST correlate with enhanced sensitivity to these novel chemotherapeutic agents.